Health Highlights: May 2, 2023
Science reveals possible ‘surge of consciousness’ before dying. These near-death experiences might be caused by a fight-or-flight response in the dying brain, researchers say. Read moreYoung guys are using banned ‘SARM’ supplements to bulk up, with ha…
Learn MoreApetamin: Using This Illegal Weight-Gain Product Can Bring Tragic Results
TUESDAY, May 2, 2023 (HealthDay News) — U.S. regulators are urging Americans to avoid Apetamin, an illegal drug used for weight gain and figure enhancement. The substance, typically sold as a syrup, is manufactured overseas, illegally imported and is…
Learn MoreAn Overlooked Issue: Prostate Cancer in Transgender Women
TUESDAY, May 2, 2023 (HealthDay News) — Transgender women have a risk of prostate cancer, even after gender-affirming surgeries, yet aren’t “on the radar” for screening by clinicians, new research finds.”The entire medical literature on prostate canc…
Learn MoreTaking Longer to Perform Tasks? It Could Be a Sign of Dementia Risk
TUESDAY, May 2, 2023 (HealthDay News) — It’s expected that seniors slow down physically as they age, but this could be a sign of more than just lost muscle strength, a new study suggests. In some, it may be a harbinger of dementia.Australian research…
Learn MoreYounger Women With AMI Have More Adverse Outcomes After Discharge
MONDAY, May 1, 2023 (HealthDay News) — Compared with men, younger women with acute myocardial infarction (AMI) have more adverse outcomes in the year following discharge, according to a study published in the May 9 issue of the Journal of the America…
Learn MoreFull Resolution of Symptoms Seen in Most Children With Lyme Disease
MONDAY, May 1, 2023 (HealthDay News) — Most children with Lyme disease experience full resolution of symptoms, according to a study published online March 30 in Pediatric Research.Maureen Monaghan, Ph.D., from The George Washington University School …
Learn MoreHIV Status Does Not Affect Outcomes of Tecovirimat Treatment for Mpox
MONDAY, May 1, 2023 (HealthDay News) — HIV status seems not to affect treatment outcomes among patients receiving tecovirimat for mpox, according to a study published online May 2 in the Annals of Internal Medicine.Jacob McLean, D.O., from the Columb…
Learn More